Mendes-Pereira AM, Lord CJ, Ashworth A.NLK is a novel therapeutic target for PTEN deficient tumour cells. PLoS One. 2012;7(10):e47249 - Stand Up To Cancer

Blog

Posted September 4, 2019

Mendes-Pereira AM, Lord CJ, Ashworth A.NLK is a novel therapeutic target for PTEN deficient tumour cells. PLoS One. 2012;7(10):e47249

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Please validate the captcha
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.